Suchergebnisse - (Subject:"Acute Lung Injury")

PubPharm (9.677)

21

Icariside II alleviates lipopolysaccharide-induced acute lung injury by inhibiting lung epithelial inflammatory and immune responses mediated by neutrophil extracellular traps

enthalten in: Life sciences | 2024

von Li, X. | Wang, Y. | Chen, Y. | +9

22

Ginsenoside Rg1 Alleviates Sepsis-Induced Acute Lung Injury by Reducing FBXO3 Stability in an $ m^{6} $A-Dependent Manner to Activate PGC-1α/Nrf2 Signaling Pathway

enthalten in: The AAPS Journal | 2024

von Liu, R. | Wang, Q. | Li, Y. | +5

23

Resveratrol alleviates acute lung injury in mice by promoting Pink1/Parkin-related mitophagy and inhibiting NLRP3 inflammasome activation

enthalten in: Biochimica et biophysica acta. General subjects | 2024

von Wu, D. | Zhang, H. | Li, F. | +5

24

Navigating the terrain of neutrophil extracellular traps in severe malaria pathogenesis

enthalten in: Trends in parasitology | 2024

von Saeed, M. | Aitken, E. | Rogerson, S.

25

A Multicenter, Random Control Study :Early Use of Airway Pressure Release Ventilation (APRVplus) Protocol in ARDS : A Multicenter, Random Control Study: Early Use of Airway Pressure Release Ventilation Updated (APRVplus) Protocol in Acute Respiratory Disease Syndrome (ARDS)

enthalten in: ClinicalTrials.gov | 2024

26

Transpulmonary Pressure in Right Ventricle Protection of ARDS : Transpulmonary Pressure Guided Mechanical Ventilation Strategy for Right Ventricle Protection in Acute Respiratory Distress Syndrome

enthalten in: ClinicalTrials.gov | 2024

27

Garlic oil supplementation blocks inflammatory pyroptosis-related acute lung injury by suppressing the NF-κB/NLRP3 signaling pathway via H2S generation

enthalten in: Aging | 2024

von Dilxat, T. | Shi, Q. | Chen, X. | +1

28

CytOSorb TreatMent Of Critically Ill PatientS Registry : CytOSorb TreatMent Of Critically Ill PatientS Registry: International Registry on the Use of CytoSorb in the Critical Care Setting

enthalten in: ClinicalTrials.gov | 2024

29

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia : A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Adult Hospitalized Subjects With CAP Including COVID-19 Pneumonia.

enthalten in: ClinicalTrials.gov | 2024

30

Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients : Systematic Ultrasound Screening for Lower Extremity Deep Vein Thrombosis in ICU Patients With Severe COVID-19: a Randomized Clinical Trial.

enthalten in: ClinicalTrials.gov | 2024